tiprankstipranks
Trending News
More News >

West Pharmaceutical initiated with an Equal Weight at Barclays

Barclays analyst Luke Sergott initiated coverage of West Pharmaceutical (WST) with an Equal Weight rating and $245 price target The company has a strong market position in its core High-Value Products unit, but in recent quarters, it has been plagued by issues in much smaller, non-core businesses, notably SmartDose and continuous glucose monitoring manufacturing, the analyst tells investors in a research note. The firm says the biggest concern for the business is oral GLP-1s coming to market.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1